A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Mannatech, Incorporated ("Mannatech" or the "Company") is a global wellness solution provider, which was incorporated and began operations in November 1993. We develop and sell innovative, high quality, proprietary nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. We currently sell our products in three regions: (i) the Americas (the United States, Canada and Mexico); (ii) Europe/the Middle East/Africa (“EMEA”) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom); and (iii) Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Thailand, Taiwan, Hong Kong, and China). We also ship our products to customers in the following countries: Belgium, France, Greece, Italy, Luxembourg, and Poland.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 169M | 118M | 132M | 137M | 160M | 151M |
| Net Income | -3.5M | 2.5M | -2.2M | -4.5M | 9.8M | 6.3M |
| EPS | $-1.84 | $1.32 | $-1.20 | $-2.35 | $4.71 | $2.77 |
| Free Cash Flow | -2.8M | 2.0M | -3.1M | -3.7M | 10M | 5.1M |
| ROIC | 1.5% | 10.0% | -21.4% | -2.9% | 37.1% | 17.3% |
| Gross Margin | 75.7% | 77.6% | 78.0% | 75.9% | 78.6% | 76.5% |
| Debt/Equity | 0.46 | 0.38 | 0.05 | 0.03 | 0.01 | 0.03 |
| Dividends/Share | $0.00 | $0.20 | $0.40 | $0.80 | $1.70 | $1,160,000.00 |
| Operating Income | 649K | 1.4M | -964K | -405K | 9.0M | 4.5M |
| Operating Margin | 0.4% | 1.2% | -0.7% | -0.3% | 5.7% | 3.0% |
| ROE | -50.6% | 26.1% | -21.4% | -31.7% | 40.3% | 24.1% |
| Shares Outstanding | 2M | 2M | 2M | 2M | 2M | 2M |
MANNATECH INC passes 3 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average ROIC is 8.0% with a gross margin of 77.3%. Total shareholder yield (dividends) is 4.1%. At current prices, the estimated annualized return to fair value is -17.0%.
MANNATECH INC (MTEX) has a 5-year average return on invested capital (ROIC) of 8.0%. This is below average and may indicate limited pricing power.
MANNATECH INC (MTEX) has a market capitalization of $9M. It is classified as a small-cap stock.
Yes, MANNATECH INC (MTEX) pays a dividend with a trailing twelve-month yield of 4.13%.
MANNATECH INC (MTEX) operates in the Medicinal Chemicals & Botanical Products industry, within the Healthcare sector.
MANNATECH INC (MTEX) reported annual revenue of $118 million in its most recent fiscal year, based on SEC EDGAR filings.
MANNATECH INC (MTEX) has a net profit margin of 2.1%. This is a modest margin.
MANNATECH INC (MTEX) generated $2 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
MANNATECH INC (MTEX) has a debt-to-equity ratio of 0.38. This indicates a conservatively financed balance sheet.
MANNATECH INC (MTEX) reported earnings per share (EPS) of $1.32 in its most recent fiscal year.
MANNATECH INC (MTEX) has a return on equity (ROE) of 26.1%. This indicates the company generates strong returns for shareholders.
MANNATECH INC (MTEX) has a 5-year average gross margin of 77.3%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 15 years of financial data for MANNATECH INC (MTEX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
MANNATECH INC (MTEX) has a book value per share of $4.57, based on its most recent annual SEC filing.